{"id":"https://openalex.org/W2070673176","doi":"https://doi.org/10.1093/clind/15.supplement_1.s206","title":"Evaluation of New Anti-Infective Drugs for the Treatment of Febrile Episodes in Neutropenic Patients","display_name":"Evaluation of New Anti-Infective Drugs for the Treatment of Febrile Episodes in Neutropenic Patients","alternate_titles":[],"publication_year":1992,"publication_date":"1992-11-01","ids":{"openalex":"https://openalex.org/W2070673176","doi":"https://doi.org/10.1093/clind/15.supplement_1.s206","mag":"2070673176","pmid":"https://pubmed.ncbi.nlm.nih.gov/1477232"},"language":"en","primary_location":{"id":"doi:10.1093/clind/15.supplement_1.s206","doi":"https://doi.org/10.1093/clind/15.supplement_1.s206","is_oa":true,"landing_page_url":"https://doi.org/10.1093/clind/15.supplement_1.s206","pdf_url":"https://academic.oup.com/cid/article-pdf/15/Supplement_1/S206/20900912/15-Supplement_1-S206.pdf","source":{"id":"https://openalex.org/S72350973","display_name":"Clinical Infectious Diseases","issn_l":"1058-4838","issn":["1058-4838","1537-6591"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Infectious Diseases","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2070673176"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://academic.oup.com/cid/article-pdf/15/Supplement_1/S206/20900912/15-Supplement_1-S206.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5109361832","display_name":"Walter T. Hughes","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I1313298211","display_name":"St. Jude Children's Research Hospital","ror":"https://ror.org/02r3e0967","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1313298211","https://openalex.org/I2802152183"]},{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]},{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4390039317","display_name":"University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center","ror":"https://ror.org/01vft3j45","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I14285509","https://openalex.org/I4390039317"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Walter T. Hughes","raw_affiliation_strings":["Division of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee 38105","From St. Jude Children's Research Hospital, Memphis, Tennessee","Memorial Sloan-Kettering Cancer Hospital and Pfizer Pharmaceuticals, New York, New York","the Kuzell Institute, San Francisco, California","the National Cancer Institute, Bethesda, Maryland","the University of Maryland Cancer Center, Baltimore, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee 38105","institution_ids":["https://openalex.org/I1313298211"]},{"raw_affiliation_string":"From St. Jude Children's Research Hospital, Memphis, Tennessee","institution_ids":["https://openalex.org/I1313298211"]},{"raw_affiliation_string":"Memorial Sloan-Kettering Cancer Hospital and Pfizer Pharmaceuticals, New York, New York","institution_ids":["https://openalex.org/I1334819555","https://openalex.org/I180857899"]},{"raw_affiliation_string":"the Kuzell Institute, San Francisco, California","institution_ids":[]},{"raw_affiliation_string":"the National Cancer Institute, Bethesda, Maryland","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"raw_affiliation_string":"the University of Maryland Cancer Center, Baltimore, Maryland","institution_ids":["https://openalex.org/I4390039317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111412782","display_name":"Philip A. Pizzo","orcid":"https://orcid.org/0000-0002-1000-6516","observed_orcids":["https://orcid.org/0000-0002-1000-6516"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I1313298211","display_name":"St. Jude Children's Research Hospital","ror":"https://ror.org/02r3e0967","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1313298211","https://openalex.org/I2802152183"]},{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]},{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4390039317","display_name":"University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center","ror":"https://ror.org/01vft3j45","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I14285509","https://openalex.org/I4390039317"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Philip A. Pizzo","raw_affiliation_strings":["From St. Jude Children's Research Hospital, Memphis, Tennessee; the National Cancer Institute, Bethesda, Maryland; the University of Maryland Cancer Center, Baltimore, Maryland; Memorial Sloan-Kettering Cancer Hospital and Pfizer Pharmaceuticals, New York, New York; and the Kuzell Institute, San Francisco, California","From St. Jude Children's Research Hospital, Memphis, Tennessee","Memorial Sloan-Kettering Cancer Hospital and Pfizer Pharmaceuticals, New York, New York","the Kuzell Institute, San Francisco, California","the National Cancer Institute, Bethesda, Maryland","the University of Maryland Cancer Center, Baltimore, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From St. Jude Children's Research Hospital, Memphis, Tennessee; the National Cancer Institute, Bethesda, Maryland; the University of Maryland Cancer Center, Baltimore, Maryland; Memorial Sloan-Kettering Cancer Hospital and Pfizer Pharmaceuticals, New York, New York; and the Kuzell Institute, San Francisco, California","institution_ids":["https://openalex.org/I1313298211","https://openalex.org/I4210140884","https://openalex.org/I4390039317"]},{"raw_affiliation_string":"From St. Jude Children's Research Hospital, Memphis, Tennessee","institution_ids":["https://openalex.org/I1313298211"]},{"raw_affiliation_string":"Memorial Sloan-Kettering Cancer Hospital and Pfizer Pharmaceuticals, New York, New York","institution_ids":["https://openalex.org/I1334819555","https://openalex.org/I180857899"]},{"raw_affiliation_string":"the Kuzell Institute, San Francisco, California","institution_ids":[]},{"raw_affiliation_string":"the National Cancer Institute, Bethesda, Maryland","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"raw_affiliation_string":"the University of Maryland Cancer Center, Baltimore, Maryland","institution_ids":["https://openalex.org/I4390039317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113794870","display_name":"James C. Wade","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I1313298211","display_name":"St. Jude Children's Research Hospital","ror":"https://ror.org/02r3e0967","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1313298211","https://openalex.org/I2802152183"]},{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]},{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4390039317","display_name":"University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center","ror":"https://ror.org/01vft3j45","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I14285509","https://openalex.org/I4390039317"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"James C. Wade","raw_affiliation_strings":["From St. Jude Children's Research Hospital, Memphis, Tennessee; the National Cancer Institute, Bethesda, Maryland; the University of Maryland Cancer Center, Baltimore, Maryland; Memorial Sloan-Kettering Cancer Hospital and Pfizer Pharmaceuticals, New York, New York; and the Kuzell Institute, San Francisco, California","From St. Jude Children's Research Hospital, Memphis, Tennessee","Memorial Sloan-Kettering Cancer Hospital and Pfizer Pharmaceuticals, New York, New York","the Kuzell Institute, San Francisco, California","the National Cancer Institute, Bethesda, Maryland","the University of Maryland Cancer Center, Baltimore, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From St. Jude Children's Research Hospital, Memphis, Tennessee; the National Cancer Institute, Bethesda, Maryland; the University of Maryland Cancer Center, Baltimore, Maryland; Memorial Sloan-Kettering Cancer Hospital and Pfizer Pharmaceuticals, New York, New York; and the Kuzell Institute, San Francisco, California","institution_ids":["https://openalex.org/I1313298211","https://openalex.org/I4210140884","https://openalex.org/I4390039317"]},{"raw_affiliation_string":"From St. Jude Children's Research Hospital, Memphis, Tennessee","institution_ids":["https://openalex.org/I1313298211"]},{"raw_affiliation_string":"Memorial Sloan-Kettering Cancer Hospital and Pfizer Pharmaceuticals, New York, New York","institution_ids":["https://openalex.org/I1334819555","https://openalex.org/I180857899"]},{"raw_affiliation_string":"the Kuzell Institute, San Francisco, California","institution_ids":[]},{"raw_affiliation_string":"the National Cancer Institute, Bethesda, Maryland","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"raw_affiliation_string":"the University of Maryland Cancer Center, Baltimore, Maryland","institution_ids":["https://openalex.org/I4390039317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5107503244","display_name":"Donald Armstrong","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I1313298211","display_name":"St. Jude Children's Research Hospital","ror":"https://ror.org/02r3e0967","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1313298211","https://openalex.org/I2802152183"]},{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]},{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4390039317","display_name":"University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center","ror":"https://ror.org/01vft3j45","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I14285509","https://openalex.org/I4390039317"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Donald Armstrong","raw_affiliation_strings":["From St. Jude Children's Research Hospital, Memphis, Tennessee; the National Cancer Institute, Bethesda, Maryland; the University of Maryland Cancer Center, Baltimore, Maryland; Memorial Sloan-Kettering Cancer Hospital and Pfizer Pharmaceuticals, New York, New York; and the Kuzell Institute, San Francisco, California","From St. Jude Children's Research Hospital, Memphis, Tennessee","Memorial Sloan-Kettering Cancer Hospital and Pfizer Pharmaceuticals, New York, New York","the Kuzell Institute, San Francisco, California","the National Cancer Institute, Bethesda, Maryland","the University of Maryland Cancer Center, Baltimore, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From St. Jude Children's Research Hospital, Memphis, Tennessee; the National Cancer Institute, Bethesda, Maryland; the University of Maryland Cancer Center, Baltimore, Maryland; Memorial Sloan-Kettering Cancer Hospital and Pfizer Pharmaceuticals, New York, New York; and the Kuzell Institute, San Francisco, California","institution_ids":["https://openalex.org/I1313298211","https://openalex.org/I4210140884","https://openalex.org/I4390039317"]},{"raw_affiliation_string":"From St. Jude Children's Research Hospital, Memphis, Tennessee","institution_ids":["https://openalex.org/I1313298211"]},{"raw_affiliation_string":"Memorial Sloan-Kettering Cancer Hospital and Pfizer Pharmaceuticals, New York, New York","institution_ids":["https://openalex.org/I1334819555","https://openalex.org/I180857899"]},{"raw_affiliation_string":"the Kuzell Institute, San Francisco, California","institution_ids":[]},{"raw_affiliation_string":"the National Cancer Institute, Bethesda, Maryland","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"raw_affiliation_string":"the University of Maryland Cancer Center, Baltimore, Maryland","institution_ids":["https://openalex.org/I4390039317"]}]},{"author_position":"middle","author":{"id":null,"display_name":"C. Douglas Webb","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I1313298211","display_name":"St. Jude Children's Research Hospital","ror":"https://ror.org/02r3e0967","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1313298211","https://openalex.org/I2802152183"]},{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]},{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4390039317","display_name":"University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center","ror":"https://ror.org/01vft3j45","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I14285509","https://openalex.org/I4390039317"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"C. Douglas Webb","raw_affiliation_strings":["From St. Jude Children's Research Hospital, Memphis, Tennessee; the National Cancer Institute, Bethesda, Maryland; the University of Maryland Cancer Center, Baltimore, Maryland; Memorial Sloan-Kettering Cancer Hospital and Pfizer Pharmaceuticals, New York, New York; and the Kuzell Institute, San Francisco, California","From St. Jude Children's Research Hospital, Memphis, Tennessee","Memorial Sloan-Kettering Cancer Hospital and Pfizer Pharmaceuticals, New York, New York","the Kuzell Institute, San Francisco, California","the National Cancer Institute, Bethesda, Maryland","the University of Maryland Cancer Center, Baltimore, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From St. Jude Children's Research Hospital, Memphis, Tennessee; the National Cancer Institute, Bethesda, Maryland; the University of Maryland Cancer Center, Baltimore, Maryland; Memorial Sloan-Kettering Cancer Hospital and Pfizer Pharmaceuticals, New York, New York; and the Kuzell Institute, San Francisco, California","institution_ids":["https://openalex.org/I1313298211","https://openalex.org/I4210140884","https://openalex.org/I4390039317"]},{"raw_affiliation_string":"From St. Jude Children's Research Hospital, Memphis, Tennessee","institution_ids":["https://openalex.org/I1313298211"]},{"raw_affiliation_string":"Memorial Sloan-Kettering Cancer Hospital and Pfizer Pharmaceuticals, New York, New York","institution_ids":["https://openalex.org/I1334819555","https://openalex.org/I180857899"]},{"raw_affiliation_string":"the Kuzell Institute, San Francisco, California","institution_ids":[]},{"raw_affiliation_string":"the National Cancer Institute, Bethesda, Maryland","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"raw_affiliation_string":"the University of Maryland Cancer Center, Baltimore, Maryland","institution_ids":["https://openalex.org/I4390039317"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5103431101","display_name":"Lowell S. Young","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I1313298211","display_name":"St. Jude Children's Research Hospital","ror":"https://ror.org/02r3e0967","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1313298211","https://openalex.org/I2802152183"]},{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]},{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4390039317","display_name":"University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center","ror":"https://ror.org/01vft3j45","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I14285509","https://openalex.org/I4390039317"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Lowell S. Young","raw_affiliation_strings":["From St. Jude Children's Research Hospital, Memphis, Tennessee; the National Cancer Institute, Bethesda, Maryland; the University of Maryland Cancer Center, Baltimore, Maryland; Memorial Sloan-Kettering Cancer Hospital and Pfizer Pharmaceuticals, New York, New York; and the Kuzell Institute, San Francisco, California","From St. Jude Children's Research Hospital, Memphis, Tennessee","Memorial Sloan-Kettering Cancer Hospital and Pfizer Pharmaceuticals, New York, New York","the Kuzell Institute, San Francisco, California","the National Cancer Institute, Bethesda, Maryland","the University of Maryland Cancer Center, Baltimore, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From St. Jude Children's Research Hospital, Memphis, Tennessee; the National Cancer Institute, Bethesda, Maryland; the University of Maryland Cancer Center, Baltimore, Maryland; Memorial Sloan-Kettering Cancer Hospital and Pfizer Pharmaceuticals, New York, New York; and the Kuzell Institute, San Francisco, California","institution_ids":["https://openalex.org/I1313298211","https://openalex.org/I4210140884","https://openalex.org/I4390039317"]},{"raw_affiliation_string":"From St. Jude Children's Research Hospital, Memphis, Tennessee","institution_ids":["https://openalex.org/I1313298211"]},{"raw_affiliation_string":"Memorial Sloan-Kettering Cancer Hospital and Pfizer Pharmaceuticals, New York, New York","institution_ids":["https://openalex.org/I1334819555","https://openalex.org/I180857899"]},{"raw_affiliation_string":"the Kuzell Institute, San Francisco, California","institution_ids":[]},{"raw_affiliation_string":"the National Cancer Institute, Bethesda, Maryland","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"raw_affiliation_string":"the University of Maryland Cancer Center, Baltimore, Maryland","institution_ids":["https://openalex.org/I4390039317"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5109361832"],"corresponding_institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I1313298211","https://openalex.org/I1334819555","https://openalex.org/I180857899","https://openalex.org/I4210140884","https://openalex.org/I4390039317"],"apc_list":{"value":4763,"currency":"USD","value_usd":4763},"apc_paid":null,"fwci":1.444,"has_fulltext":true,"cited_by_count":98,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.83201941,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":98},"biblio":{"volume":"15","issue":"Supplement_1","first_page":"S206","last_page":"S215"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12172","display_name":"Neutropenia and Cancer Infections","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12172","display_name":"Neutropenia and Cancer Infections","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10150","display_name":"Antifungal resistance and susceptibility","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11232","display_name":"Urinary Tract Infections Management","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2748","display_name":"Urology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/febrile-neutropenia","display_name":"febrile neutropenia","score":0.9779999852180481},{"id":"https://openalex.org/keywords/anti-infective-agents","display_name":"anti-infective agents","score":0.7829999923706055},{"id":"https://openalex.org/keywords/empirical-antimicrobial-therapy","display_name":"empirical antimicrobial therapy","score":0.9539999961853027},{"id":"https://openalex.org/keywords/drug-efficacy-and-safety","display_name":"drug safety and efficacy","score":0.6100000143051147},{"id":"https://openalex.org/keywords/clinical-trials","display_name":"clinical trials","score":0.44699999690055847},{"id":"https://openalex.org/keywords/cancer-patients","display_name":"cancer patients","score":0.7360000014305115},{"id":"https://openalex.org/keywords/microbiological-outcomes","display_name":"microbiological outcomes","score":0.7639999985694885},{"id":"https://openalex.org/keywords/clinical-outcomes","display_name":"clinical outcomes","score":0.8220000267028809}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9362639784812927},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.666088342666626},{"id":"https://openalex.org/C2778850193","wikidata":"https://www.wikidata.org/wiki/Q3775974","display_name":"Febrile neutropenia","level":4,"score":0.6299279928207397},{"id":"https://openalex.org/C4937899","wikidata":"https://www.wikidata.org/wiki/Q68541106","display_name":"Antimicrobial","level":2,"score":0.5683257579803467},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.5173163414001465},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.5159748196601868},{"id":"https://openalex.org/C2780182762","wikidata":"https://www.wikidata.org/wiki/Q1630279","display_name":"Guideline","level":2,"score":0.4961622655391693},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.48741820454597473},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4767875671386719},{"id":"https://openalex.org/C137627325","wikidata":"https://www.wikidata.org/wiki/Q156318","display_name":"Etiology","level":2,"score":0.4724721610546112},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4414823055267334},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.42503368854522705},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.22740113735198975},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.0},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000890","descriptor_name":"Anti-Infective Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002985","descriptor_name":"Clinical Protocols","qualifier_ui":"Q000592","qualifier_name":"standards","is_major_topic":false},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":"Q000592","qualifier_name":"standards","is_major_topic":true},{"descriptor_ui":"D005334","descriptor_name":"Fever","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D005334","descriptor_name":"Fever","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007239","descriptor_name":"Infections","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D007239","descriptor_name":"Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009503","descriptor_name":"Neutropenia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009503","descriptor_name":"Neutropenia","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D012107","descriptor_name":"Research Design","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017321","descriptor_name":"Clinical Trials, Phase I as Topic","qualifier_ui":"Q000592","qualifier_name":"standards","is_major_topic":false},{"descriptor_ui":"D017322","descriptor_name":"Clinical Trials, Phase II as Topic","qualifier_ui":"Q000592","qualifier_name":"standards","is_major_topic":false},{"descriptor_ui":"D017326","descriptor_name":"Clinical Trials, Phase III as Topic","qualifier_ui":"Q000592","qualifier_name":"standards","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1093/clind/15.supplement_1.s206","doi":"https://doi.org/10.1093/clind/15.supplement_1.s206","is_oa":true,"landing_page_url":"https://doi.org/10.1093/clind/15.supplement_1.s206","pdf_url":"https://academic.oup.com/cid/article-pdf/15/Supplement_1/S206/20900912/15-Supplement_1-S206.pdf","source":{"id":"https://openalex.org/S72350973","display_name":"Clinical Infectious Diseases","issn_l":"1058-4838","issn":["1058-4838","1537-6591"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Infectious Diseases","raw_type":"journal-article"},{"id":"pmid:1477232","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/1477232","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","raw_type":"Guideline"}],"best_oa_location":{"id":"doi:10.1093/clind/15.supplement_1.s206","doi":"https://doi.org/10.1093/clind/15.supplement_1.s206","is_oa":true,"landing_page_url":"https://doi.org/10.1093/clind/15.supplement_1.s206","pdf_url":"https://academic.oup.com/cid/article-pdf/15/Supplement_1/S206/20900912/15-Supplement_1-S206.pdf","source":{"id":"https://openalex.org/S72350973","display_name":"Clinical Infectious Diseases","issn_l":"1058-4838","issn":["1058-4838","1537-6591"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Infectious Diseases","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G6709908151","display_name":null,"funder_award_id":"HHS 223-88-1301","funder_id":"https://openalex.org/F4320332177","funder_display_name":"Agency for Healthcare Research and Quality"}],"funders":[{"id":"https://openalex.org/F4320332177","display_name":"Agency for Healthcare Research and Quality","ror":"https://ror.org/03jmfdf59"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2070673176.pdf","grobid_xml":"https://content.openalex.org/works/W2070673176.grobid-xml"},"referenced_works_count":6,"referenced_works":["https://openalex.org/W2044521096","https://openalex.org/W2108818954","https://openalex.org/W2255483994","https://openalex.org/W2335721167","https://openalex.org/W2418377760","https://openalex.org/W4250071550"],"related_works":["https://openalex.org/W1499092497","https://openalex.org/W2189323632","https://openalex.org/W2329388483","https://openalex.org/W2120914386","https://openalex.org/W4391122256","https://openalex.org/W2088563395","https://openalex.org/W45918394","https://openalex.org/W2752539345","https://openalex.org/W2467480707","https://openalex.org/W2465789807"],"abstract_inverted_index":{"The":[0],"use":[1],"of":[2,26,31,38,67,69],"empirical":[3],"antimicrobial":[4,33],"therapy":[5],"has":[6],"significantly":[7],"reduced":[8],"the":[9,27,65,79],"morbidity":[10],"and":[11,29,41,71,73,94],"mortality":[12],"associated":[13],"with":[14,56,89,105],"untreated":[15],"infections":[16],"in":[17,35,47,78],"febrile":[18],"neutropenic":[19],"patients.":[20,39],"This":[21],"guideline":[22],"describes":[23],"clinical":[24,109],"trials":[25],"safety":[28],"efficacy":[30],"new":[32,58],"drugs":[34],"this":[36],"population":[37],"Fever":[40],"neutropenia":[42],"should":[43,51,83],"be":[44,52,84],"precisely":[45],"defined":[46,77,91],"each":[48],"protocol.":[49],"Patients":[50],"randomized":[53],"to":[54],"treatment":[55],"a":[57,90],"or":[59],"active-control":[60],"drug":[61],"regimen,":[62],"stratified":[63],"on":[64],"basis":[66],"type":[68],"cancer":[70],"age,":[72],"treated":[74],"until":[75],"resolution--as":[76],"protocol--is":[80],"attained.":[81],"Outcome":[82],"assessed":[85],"both":[86],"for":[87,95,103],"cases":[88,104],"microbial":[92],"etiology":[93],"those":[96],"without.":[97],"Final":[98],"microbiological":[99],"outcome":[100,110],"is":[101,111],"important":[102],"identified":[106],"pathogens,":[107],"but":[108],"paramount.":[112]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2070673176","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":5},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
